Universitätsklinikum Jena

Factors associated with long-term survival after failure a chimeric antigen receptor (CAR) T cell therapy for relapsed or refractory large B-cell lymphomas:a role for allogeneic stem cell transplantation? (2022) Derigs P, Bethge W, Holtick U, Von Tresckow B, Ayuk F, Penack O, Vucinic V, et al. Conference contribution Prophylaxis of bacterial Infections and Pneumocystis jirovecii pneumonia in Female Patients with hematological and oncological Diseases: Updated Guideline of the Working Group on Infections (AGIHO) of the German Society for Hematology and Oncology (DGHO) (2022) Classen AY, Henze L, Von Lilienfeld-Toal M, Maschmeyer G, Sandherr M, Duran GL, Alakel N, et al. Conference contribution Antifungal effect of cold atmospheric plasma in a 3D model of cutaneous candidiasis (2022) Fink S, Fischer M, Stubenrauch M, Horn K, Spange S, Pfuch A, Muller J, et al. Conference contribution DEGRO practical guideline for central nervous system radiation necrosis part 2: treatment (2022) Bernhardt D, Koenig L, Grosu AL, Rieken S, Krieg SM, Wick W, Wiestler B, et al. Journal article, Review article Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial (2022) Zimmermann H, Koenecke C, Dreyling MH, Pott C, Duehrsen U, Hahn D, Meidenbauer N, et al. Journal article Foreword of the DGHO Executive Board Vorwort des DGHO-Vorstandes (2022) Einsele H, Hochhaus A, De Wit M, Schulz CO Journal article Clinical trials in hematology and oncology Klinische Studien in der Hämatologie und Onkologie (2022) Einsele H, Steutel H, Eichhorst B, Gobeler ME, Hochhaus A, Nickel L, Von Messling V, et al. Journal article Relationship between age at initiation of cysteamine treatment, adherence with therapy, and glomerular kidney function in infantile nephropathic cystinosis (2022) Nießl C, Boulesteix AL, Oh J, Palm K, Schlingmann P, Wygoda S, Haffner D, et al. Journal article ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia (2022) Schoenfeld L, Rinke J, Hinze A, Nagel SN, Schaefer V, Schenk T, Fabisch C, et al. Journal article GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany (2022) Bethge WA, Martus P, Schmitt M, Holtick U, Subklewe M, von Tresckow B, Ayuk F, et al. Journal article